Drug Profile
Zalcitabine
Alternative Names: D 2C; ddC; Dideoxycytidine; Hivid; NSC 606170; RO 24-2027/000Latest Information Update: 23 Sep 2021
Price :
$50
*
At a glance
- Originator Roche
- Class Antiretrovirals; Deoxyribonucleosides; Dideoxynucleosides; Pyrimidine nucleosides; Small molecules
- Mechanism of Action RNA-directed DNA polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Market Withdrawal HIV infections
Most Recent Events
- 09 Jul 1999 Coronavirus-DNA-vaccine-NIAID Coronavirus-DNA-vaccine-VRC/NIAID
- 22 Jan 1999 Launched for HIV infections treatment in Australia (PO)
- 02 Jun 1998 Launched for HIV infections treatment in Spain (PO)